Andrew J. Schwab - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew J. Schwab since 25 May 2025

Holdings reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Form 4 holding Director, 10%+ Owner

Enliven Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
27,567
Estimated value
Report date
23 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .